These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 22455172)

  • 1. The case of the rapid rituximab regimen.
    Eisenberg S
    ONS Connect; 2012 Mar; 27(3):18. PubMed ID: 22455172
    [No Abstract]   [Full Text] [Related]  

  • 2. Rapid development of infusion-related severe hypotension during rituximab therapy.
    Vo KH; Waddell JA; Suda KJ
    Ann Pharmacother; 2011 May; 45(5):e29. PubMed ID: 21505107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnose, assess, and manage infusion reactions.
    Becze E
    ONS Connect; 2010 Jul; 25(7):12-3. PubMed ID: 20669809
    [No Abstract]   [Full Text] [Related]  

  • 4. Chemotherapy by catheter.
    Alderman C
    Nurs Stand; 1998 Apr 1-7; 12(28):25-7. PubMed ID: 9616621
    [No Abstract]   [Full Text] [Related]  

  • 5. Chronotherapeutic drug delivery.
    Librodo P; Buckley M; Luk M; Bisso A
    J Infus Nurs; 2012; 35(5):329-34. PubMed ID: 22955155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Subcutaneous Rituximab is effective and safe].
    Häckel A
    Med Monatsschr Pharm; 2014 Jan; 37(1):39-40. PubMed ID: 24490439
    [No Abstract]   [Full Text] [Related]  

  • 7. Systemic rituximab in multifocal primary cutaneous follicle centre lymphoma.
    Quéreux G; Brocard A; Peuvrel L; Nguyen JM; Knol AC; Dréno B
    Acta Derm Venereol; 2011 Sep; 91(5):562-7. PubMed ID: 21629975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase 1 clinical trials nursing: determining safety and side effects on the road approval.
    Lindberg D
    ONS Connect; 2012 Jul; 27(7):10-4. PubMed ID: 22855983
    [No Abstract]   [Full Text] [Related]  

  • 9. The case of the painful port.
    Eisenberg S
    ONS Connect; 2012 Jan; 27(1):19. PubMed ID: 22355897
    [No Abstract]   [Full Text] [Related]  

  • 10. Rituximab-related urticarial reaction overlying primary cutaneous follicle centre lymphoma: histological appearance and pathophysiological hypotheses.
    Ingen-Housz-Oro S; Ortonne N; Chosidow O
    J Eur Acad Dermatol Venereol; 2014 Jul; 28(7):976-8. PubMed ID: 24206369
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluation of safe infusion devices for antineoplastic administration.
    Lalande L; Galy G; Dussossoy E; Noyel JE; Pivot C
    J Infus Nurs; 2012; 35(5):321-7. PubMed ID: 22955154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How much time do nurses need to give chemotherapy?
    Becze E
    ONS Connect; 2011 Jan; 26(1):14-5. PubMed ID: 21355484
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing chemotherapy-related cognitive impairment.
    Becze E
    ONS Connect; 2012 Mar; 27(3):16-7. PubMed ID: 22455171
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antineoplastic chemotherapy. The standards and nursing care relative to the preparation and administration of antineoplastic therapy].
    Santos ME
    Servir; 1988; 36(6):296-301. PubMed ID: 3149013
    [No Abstract]   [Full Text] [Related]  

  • 15. Additional issues raised on blood returns and ports.
    Morris DJ
    Oncol Nurs Forum; 2000 Sep; 27(8):1202-3. PubMed ID: 11013901
    [No Abstract]   [Full Text] [Related]  

  • 16. The case of anticipated alopecia.
    Eisenberg S
    ONS Connect; 2011 Jul; 26(7):17. PubMed ID: 21877440
    [No Abstract]   [Full Text] [Related]  

  • 17. Risk factors for rituximab-induced interstitial lung diseases in patients with malignant lymphoma.
    Cha SI; Choi KJ; Shin KM; Lim J; Yoo SS; Lee J; Lee SY; Kim CH; Park JY
    Respiration; 2013; 85(2):175. PubMed ID: 23234874
    [No Abstract]   [Full Text] [Related]  

  • 18. Keys to unlock cancer: targeted therapy.
    Viele CS
    Oncol Nurs Forum; 2005 Sep; 32(5):935-40. PubMed ID: 16136192
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical trials of parenteral antineoplastic agents.
    Cusack G
    J Intraven Nurs; 1998; 21(6):339-43. PubMed ID: 10392099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reader looking for guidelines/policies on continuous infusion vesicants for assessments.
    Parran L
    Oncol Nurs Forum; 2000 Sep; 27(8):1201-2. PubMed ID: 11013900
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.